We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$337M
AUM Growth
+$49.1M
Cap. Flow
+$31.3M
Cap. Flow %
9.29%
Top 10 Hldgs %
34.71%
Holding
367
New
45
Increased
29
Reduced
69
Closed
17
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
O icon
26
Realty Income
O
$58.6B
$3.55M 1.05%
64,345
-337
-0.5% -$18.6K
KO icon
27
Coca-Cola
KO
$386B
$3.33M 0.99%
72,177
SYK icon
28
Stryker
SYK
$127B
$3.2M 0.95%
17,990
-235
-1% -$40.1K
WLY icon
29
John Wiley & Sons Class A
WLY
$2.73B
$3.19M 0.95%
52,650
-590
-1% -$36.7K
MSFT icon
30
Microsoft
MSFT
$3.81T
$3.18M 0.94%
27,810
-350
-1% -$37.9K
AMZN icon
31
Amazon
AMZN
$2.87T
$3.13M 0.93%
31,220
+7,520
+32% +$707K
MKC icon
32
McCormick & Company Non-Voting
MKC
$14.9B
$2.96M 0.88%
44,870
+50
+0.1% +$3.08K
HP icon
33
Helmerich & Payne
HP
$4.25B
$2.84M 0.84%
41,345
+1,385
+3% +$88.4K
TD icon
34
Toronto Dominion Bank
TD
$199B
$2.82M 0.84%
46,336
-200
-0.4% -$11.9K
TFX icon
35
Teleflex
TFX
$5.92B
$2.6M 0.77%
9,759
-400
-4% -$104K
RTX icon
36
RTX Corp
RTX
$285B
$2.58M 0.76%
29,293
+159
+0.5% +$13.4K
DD icon
37
DuPont de Nemours
DD
$18.5B
$2.47M 0.73%
15,163
-119
-0.8% -$20.5K
GOOG icon
38
Alphabet (Google) Class C
GOOG
$4.19T
$2.3M 0.68%
38,320
+20,060
+110% +$1.2M
CELG
39
DELISTED
Celgene Corp
CELG
$2.27M 0.67%
25,330
+315
+1% +$27.8K
USB.PRM
40
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$2.26M 0.67%
+82,875
New +$2.3M
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.08T
$2.25M 0.67%
10,495
-200
-2% -$41K
GILD icon
42
Gilead Sciences
GILD
$181B
$2.19M 0.65%
28,360
+880
+3% +$66.5K
VRTX icon
43
Vertex Pharmaceuticals
VRTX
$137B
$2.16M 0.64%
11,200
+100
+0.9% +$17.8K
TRP icon
44
TC Energy
TRP
$64.4B
$2.14M 0.63%
52,829
MRK icon
45
Merck
MRK
$366B
$1.99M 0.59%
29,423
-1,106
-4% -$70.5K
PFE icon
46
Pfizer
PFE
$159B
$1.98M 0.59%
47,419
-964
-2% -$37.1K
FFIV icon
47
F5
FFIV
$22.3B
$1.73M 0.51%
8,675
-30
-0.3% -$5.49K
MAR icon
48
Marriott International
MAR
$91.5B
$1.66M 0.49%
12,532
HCI icon
49
HCI Group
HCI
$2.32B
$1.61M 0.48%
36,700
+1,000
+3% +$41.4K
CHX
50
DELISTED
ChampionX
CHX
$1.59M 0.47%
36,502
-1,412
-4% -$59.2K

Similar funds

American Research & Management Company's Q3 2018 Portfolio in Review

As of Q3 2018, American Research & Management Company held 367 positions worth $337M, up 17% from $288M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

American Research & Management Company deployed $31.3M of net new capital in Q3 2018, opening 45 new positions and adding to 29 existing holdings. Its largest new stake was U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul: 82,875 shares worth $2.26M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was GE Aerospace, an estimated $404K trimmed.

  • American Research & Management Company's largest Q3 2018 buy was U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul: 82,875 shares worth $2.26M.
  • American Research & Management Company added most to Alphabet (Google) Class C in Q3 2018, an estimated $1.2M increase.
  • American Research & Management Company's biggest Q3 2018 reduction was GE Aerospace, cutting an estimated $404K.
  • American Research & Management Company fully exited Edwards Lifesciences in Q3 2018, selling an estimated $1.14M.
  • American Research & Management Company's ten largest holdings make up 35% of its $337M portfolio in Q3 2018.
  • American Research & Management Company opened 45 new positions and closed 17 in Q3 2018.
  • American Research & Management Company's portfolio value rose 17% quarter-over-quarter to $337M.

Based on American Research & Management Company's 13F filing for Q3 2018, filed 4 Oct 2018.